Drug Resistance  11/16/2005
The Fourth MIM Pan-African Malaria Conference, Yaoundé, Cameroon

 

View Webcast ( video ) ( transcript )

Chairs:

Robert Guiguemde

Fred Kironde

Speakers:

108. Drug resistance surveillance in Africa
Wilfred Mbacham, Ph.D., University of Yaounde

109. Are mutations in Plasmodium falciparum dihydrofolate reductase (DHFR) and dihdrypteroate synthase (DHPS) genes from southern Mozambique increasing?
Jaishree Raman, Malaria Research Programme, Medical Research Council

110. Point mutations in dhfr, dhps, pfcrt and pfmdr1 P. falciparum genes within a clinical trial of intermittent preventive treatment (IPT) in infants
Alfredo Mayor

111. CANCELLED -- High prevalence of the molecular chloroquine resistance marker pfcrt K76T and evidence for cross-resistance to amodiaquine in ghanaian infants
Samuel Adjei, acting director-general, Ghana Health Service

112. Pfcrt-based 76T mutation for evaluating chloroquine efficacy in malaria from ecologically distinct regions of Cameroon
Marie-Solange Evehe

113. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and in vivo response to sulfadoxine-pyrimethamine treatment in children from Nigeria
Ernest Tambo, Malaria Research Laboratories

---

Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news, and events.

• Consult our Frequently Asked Questions or How to View.
• Contact us by email with any comments, problems, suggestions.
• Call the kaisernetwork.org Help Desk at 202-347-5270.

Change Your Video Preferences